← Open Payments lookup

JULIANA FROSCH: Open Payments

NPI 1578541272 · AMHERST, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$4,384 in 55 payments from 11 companies in 2025. Trend: 2023 $12,280 · 2024 $6,450 · 2025 $4,384

Speaker / faculty: $2,750Food & beverage: $1,578Travel & lodging: $56
CompanyPaymentsAmount
ABBVIE INC.6$2,845
Janssen Pharmaceuticals, Inc11$387
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)6$253
Neurocrine BioSciences, Inc.5$213
Otsuka America Pharmaceutical, Inc.11$186
E.R. Squibb & Sons, L.L.C.4$176
Teva Pharmaceuticals USA, Inc.1$109
Vanda Pharmaceuticals Inc.5$97
Axsome Therapeutics, Inc.3$60
Alkermes, Inc.2$34

Products named: VRAYLAR, CAPLYTA, INVEGA SUSTENNA, INGREZZA, COBENFY, SPRAVATO, REXULTI, UZEDY.

Industry payments across VA — which companies pay providers there.